BMC Nephrology (Feb 2022)

Biopsy-proven kidney involvement in hypocomplementemic urticarial vasculitis

  • Alice Corthier,
  • Marie Jachiet,
  • Daniel Bertin,
  • Aude Servais,
  • Christelle Barbet,
  • Adrien Bigot,
  • Marie-Sylvie Doutre,
  • Didier Bessis,
  • Ancuta Bouffandeau,
  • Olivier Moranne,
  • Pierre-André Jarrot,
  • Nathalie Bardin,
  • Benjamin Terrier,
  • Stephane Burtey,
  • Xavier Puéchal,
  • Laurent Daniel,
  • Noémie Jourde-Chiche

DOI
https://doi.org/10.1186/s12882-022-02689-8
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Background Hypocomplementemic urticarial vasculitis (HUV) is a rare systemic vasculitis. We aimed to describe the kidney involvement of HUV in a multicenter national cohort with an extended follow-up. Methods All patients with HUV (international Schwartz criteria) with a biopsy-proven kidney involvement, identified through a survey of the French Vasculitis Study Group (FVSG), were included. A systematic literature review on kidney involvement of HUV was performed. Results Twelve patients were included, among whom 8 had positive anti-C1q antibodies. All presented with proteinuria, from mild to nephrotic, and 8 displayed acute kidney injury (AKI), requiring temporary haemodialysis in 2. Kidney biopsy showed membrano-proliferative glomerulonephritis (MPGN) in 8 patients, pauci-immune crescentic GN or necrotizing vasculitis in 3 patients (with a mild to severe interstitial inflammation), and an isolated interstitial nephritis in 1 patient. C1q deposits were observed in the glomeruli (n = 6), tubules (n = 4) or renal arterioles (n = 3) of 8 patients. All patients received corticosteroids, and 9 were also treated with immunosuppressants or apheresis. After a mean follow-up of 8.9 years, 6 patients had a preserved renal function, but 2 patients had developed stage 3–4 chronic kidney disease (CKD) and 4 patients had reached end-stage kidney disease (ESKD), among whom 1 had received a kidney transplant. Conclusion Renal involvement of HUV can be responsible for severe AKI, CKD and ESRD. It is not always associated with circulating anti-C1q antibodies. Kidney biopsy shows mostly MPGN or crescentic GN, with frequent C1q deposits in the glomeruli, tubules or arterioles.

Keywords